Literature DB >> 25907441

5-HT1B autoreceptors differentially modulate the expression of conditioned fear in a circuit-specific manner.

Y Liu1, M A Kelly2, T J Sexton3, J F Neumaier4.   

Abstract

Located in the nerve terminals of serotonergic neurons, 5-HT1B autoreceptors are poised to modulate synaptic 5-HT levels with precise temporal and spatial control, and play an important role in various emotional behaviors. This study characterized two novel, complementary viral vector strategies to investigate the contribution of 5-HT1B autoreceptors to fear expression, displayed as freezing, during contextual fear conditioning. Increased expression of 5-HT1B autoreceptors throughout the brain significantly decreased fear expression in both wild-type (WT) and 5-HT1B knockout (1BKO) mice when receptor levels were increased with a cell-type-specific herpes simplex virus (HSV) vector injected into the dorsal raphe nucleus (DRN). Additional studies used an intersectional viral vector strategy, in which an adeno-associated virus containing a double-floxed inverted sequence for the 5-HT1B receptor (AAV-DIO-1B) was combined with the retrogradely transported canine adenovirus-2 expressing Cre (CAV-Cre) in order to increase 5-HT1B autoreceptor expression only in neurons projecting from the DRN to the amygdala. Surprisingly, selective expression of 5-HT1B autoreceptors in just this circuit led to an increase in fear expression in WT, but not 1BKO, mice. These results suggest that activation of 5-HT1B autoreceptors throughout the brain may have an overall effect of attenuating fear expression, but activation of subsets of 5-HT1B autoreceptors in particular brain regions, reflecting distinct projections of serotonergic neurons from the DRN, may have disparate contributions to the ultimate response.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adeno-associated virus; amygdala; canine adenovirus-2; dorsal raphe; serotonin; viral vector

Mesh:

Substances:

Year:  2015        PMID: 25907441      PMCID: PMC4450084          DOI: 10.1016/j.neuroscience.2015.04.032

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  102 in total

1.  Anterograde neuronal circuit tracing using a genetically modified herpes simplex virus expressing EGFP.

Authors:  Alice E McGovern; Nicholas Davis-Poynter; Joanna Rakoczy; Simon Phipps; David G Simmons; Stuart B Mazzone
Journal:  J Neurosci Methods       Date:  2012-06-09       Impact factor: 2.390

Review 2.  Use of herpes virus amplicon vectors to study brain disorders.

Authors:  Rachael L Neve; Kim A Neve; Eric J Nestler; William A Carlezon
Journal:  Biotechniques       Date:  2005-09       Impact factor: 1.993

3.  Transgene expression in target-defined neuron populations mediated by retrograde infection with adeno-associated viral vectors.

Authors:  Markus Rothermel; Daniela Brunert; Christine Zabawa; Marta Díaz-Quesada; Matt Wachowiak
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

Review 4.  Viral vector approaches to modify gene expression in the brain.

Authors:  Alessandro Papale; Milica Cerovic; Riccardo Brambilla
Journal:  J Neurosci Methods       Date:  2009-08-20       Impact factor: 2.390

5.  Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination.

Authors:  G Lee; I Saito
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

6.  5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

Review 7.  Neuronal circuits of fear extinction.

Authors:  Cyril Herry; Francesco Ferraguti; Nicolas Singewald; Johannes J Letzkus; Ingrid Ehrlich; Andreas Lüthi
Journal:  Eur J Neurosci       Date:  2010-02-11       Impact factor: 3.386

Review 8.  Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research.

Authors:  W A Carlezon; E J Nestler; R L Neve
Journal:  Crit Rev Neurobiol       Date:  2000

Review 9.  Modulation of anxiety circuits by serotonergic systems.

Authors:  Christopher A Lowry; Philip L Johnson; Anders Hay-Schmidt; Jens Mikkelsen; Anantha Shekhar
Journal:  Stress       Date:  2005-12       Impact factor: 3.493

10.  Induction of a serotonergic and neuronal phenotype in thyroid C-cells.

Authors:  M S Clark; T M Lanigan; N M Page; A F Russo
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

View more
  5 in total

1.  5-HT1B Receptor-Mediated Activation of ERK1/2 Requires Both Gαi/o and β-Arrestin Proteins.

Authors:  Yusha Liu; Alec W Gibson; Marjorie R Levinstein; Atom J Lesiak; Shao-En Ong; John F Neumaier
Journal:  ACS Chem Neurosci       Date:  2019-04-29       Impact factor: 4.418

2.  Median raphe region stimulation alone generates remote, but not recent fear memory traces.

Authors:  Diána G Balázsfi; Dóra Zelena; Lívia Farkas; Kornél Demeter; István Barna; Csaba Cserép; Virág T Takács; Gábor Nyíri; Flóra Gölöncsér; Beáta Sperlágh; Tamás F Freund; József Haller
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

Review 3.  The role of 5-HT receptors in depression.

Authors:  Christine N Yohn; Mark M Gergues; Benjamin Adam Samuels
Journal:  Mol Brain       Date:  2017-06-24       Impact factor: 4.041

4.  Differences in neurotropism and neurotoxicity among retrograde viral tracers.

Authors:  Leqiang Sun; Yajie Tang; Keji Yan; Jinsong Yu; Yanyan Zou; Weize Xu; Ke Xiao; Zhihui Zhang; Weiming Li; Beili Wu; Zhe Hu; Kening Chen; Zhen F Fu; Jinxia Dai; Gang Cao
Journal:  Mol Neurodegener       Date:  2019-02-08       Impact factor: 14.195

5.  Alterations in serotonin transporter and body image-related cognition in anorexia nervosa.

Authors:  Masamichi Yokokura; Tatsuhiro Terada; Tomoyasu Bunai; Kyoko Nakaizumi; Yasuhiko Kato; Etsuji Yoshikawa; Masami Futatsubashi; Katsuaki Suzuki; Hidenori Yamasue; Yasuomi Ouchi
Journal:  Neuroimage Clin       Date:  2019-07-03       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.